JOINT FILING AGREEMENTJoint Filing Agreement • December 20th, 2024 • Samsara BioCapital, L.P. • Pharmaceutical preparations
Contract Type FiledDecember 20th, 2024 Company IndustryWe, the undersigned, hereby express our agreement that the Schedule 13G (or any amendments thereto) relating to the Common Stock of Palvella Therapeutics, Inc. is filed on behalf of each of us.
JOINT FILING AGREEMENTJoint Filing Agreement • February 24th, 2023 • Samsara BioCapital, L.P. • Pharmaceutical preparations
Contract Type FiledFebruary 24th, 2023 Company IndustryIn accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that they are jointly filing this statement on Schedule 13D. Each of them is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.